Ratio Review: Analyzing Aquestive Therapeutics Inc (AQST)’s Price-to-Cash and Price-to-Free Cash Flow

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 2.57 million shares were traded.

Ratios:

Our goal is to gain a better understanding of AQST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.48 and its Current Ratio is at 4.87.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on December 17, 2024, initiated with a Overweight rating and assigned the stock a target price of $17.

On May 10, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $8.

On April 11, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $10.Piper Sandler initiated its Overweight rating on April 11, 2024, with a $10 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 26 ’24 when Jung Cassie sold 44 shares for $4.87 per share. The transaction valued at 214 led to the insider holds 0 shares of the business.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 4.36.

Stock Price History:

Over the past 52 weeks, AQST has reached a high of $5.80, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is -14.00%, while the 200-Day Moving Average is calculated to be -36.70%.

Shares Statistics:

A total of 99.32M shares are outstanding, with a floating share count of 87.10M. Insiders hold about 12.31% of the company’s shares, while institutions hold 42.69% stake in the company.

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.